BBS-Bioactive Bone Substitutes (BBS) is a biomedical technology company developing innovative, biologically active medical device implants to be used in orthopedic surgery. Our first product, ARTEBONE®, is made from a natural animal source of bone material that has a superior capability of bone regeneration compared to existing products. Trading in the shares began on the First North Growth Finland marketplace under the share trading code ”BONEH” and on the First North Growth Sweden marketplace under the share trading code “BONES” on 28 February 2018. Stockholm Certified Advisers AB in Sweden acts as the Company’s Certified Advisors under First North Nordic Rulebook. Keywords: bone healing, new trends in bone healing, bone growth factors, investors, Nasdaq